Gupta et al. have recently reported that CCR9-CCL25 interaction promotes lung cancer progression by facilitating the migration, invasion and metastasis of lung cancer cells, and it selectively modulates the expression of key metastatic factors (MMPs and TIMPs) in lung cancer cells following CCL25 treatment [26]. The gene discussed is CCL25; the disease is lung carcinoma.